Buy Verona Pharma Stock | VRNA Stock Price & Latest News | Public
VRNA

Verona Pharma

$0.00 (0.00%)Today
    High Risk

    About VRNA

    Verona Pharma Plc operates as a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. Its lead product candidate, ensifentrine, has the potential to be the first therap...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.31
    -0.62
    -0.93
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.35

    Actual EPS
    Q4 2020

    Stats

    Market Cap$376,2M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$15.71
    1 Year Low$2.01
    Open$7.12
    High$7.28
    Low$7.12

    Buy any stock with any amount of money.

    Download the App
    Download the app